Plasma Sphingolipids Mediate a Relationship between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise

Kelsey A. Eakin, Mahwesh Saleem, Nathan Herrmann, Hugo Cogo-Moreira, Michelle M Mielke, Paul I. Oh, Norman J. Haughey, Swarajya L.V. Venkata, Krista L. Lanctôt, Walter Swardfager

Research output: Contribution to journalArticle

Abstract

Background: Exercise prevents recurrent cardiovascular events and it may combat cognitive decline in coronary artery disease (CAD); however, evidence in type 2 diabetes (T2DM) has been mixed. T2DM and memory decline have been associated with differences in the plasma sphingolipidome. Objective: Here, we will investigate whether T2DM-related sphingolipids predict less memory improvement over an exercise intervention for CAD. Methods: Among participants with CAD entering a 6-month exercise intervention, we matched 20 with T2DM to 40 without T2DM for age, sex, and body mass index. We assessed 45 sphingolipid species using high-performance liquid chromatography coupled electrospray ionization tandem mass spectrometry with multiple reaction monitoring. We assessed memory using the California Verbal Learning Test, 2nd Ed, and the revised Brief Visuospatial Learning Test. Results: Partial least squares discriminant analysis identified 8 species that distinguished T2DM from non-T2DM groups with 83% (95% confidence interval [70%, 95%]) accuracy in a receiver operator characteristic curve (validated by internal resampling, 1000 permutations, p=0.01). At baseline, T2DM-associated sphingolipids (ceramide C22:0, monohexylceramide C16:1, and lactosylceramide C24:0) were associated with poorer memory, attention, and psychomotor processing speed performance. Among 50 completers, an indirect effect of T2DM on less improvement in verbal memory was mediated by monohexylceramide C16:1 (0.86 fewer words recalled, 95% bootstrap confidence interval [-2.32, -0.24]), and an indirect effect of T2DM on less visuospatial memory improvement was mediated by ceramide C22:0 concentrations (0.42 fewer points, 95% bootstrap confidence interval [-1.17, -0.05]). Conclusions: Ceramide species associated with T2DM predicted poorer cognitive responses to exercise in patients with CAD.

Original languageEnglish (US)
Pages (from-to)717-727
Number of pages11
JournalJournal of Alzheimer's Disease
Volume69
Issue number3
DOIs
StatePublished - Jan 1 2019

Fingerprint

Sphingolipids
Type 2 Diabetes Mellitus
Coronary Artery Disease
Exercise
Confidence Intervals
Verbal Learning
Electrospray Ionization Mass Spectrometry
Ceramides
Discriminant Analysis
Tandem Mass Spectrometry
Least-Squares Analysis
Body Mass Index
High Pressure Liquid Chromatography
Learning

Keywords

  • Cognition
  • coronary artery disease
  • exercise
  • memory
  • sphingolipids
  • type 2 diabetes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Plasma Sphingolipids Mediate a Relationship between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise. / Eakin, Kelsey A.; Saleem, Mahwesh; Herrmann, Nathan; Cogo-Moreira, Hugo; Mielke, Michelle M; Oh, Paul I.; Haughey, Norman J.; Venkata, Swarajya L.V.; Lanctôt, Krista L.; Swardfager, Walter.

In: Journal of Alzheimer's Disease, Vol. 69, No. 3, 01.01.2019, p. 717-727.

Research output: Contribution to journalArticle

Eakin, KA, Saleem, M, Herrmann, N, Cogo-Moreira, H, Mielke, MM, Oh, PI, Haughey, NJ, Venkata, SLV, Lanctôt, KL & Swardfager, W 2019, 'Plasma Sphingolipids Mediate a Relationship between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise', Journal of Alzheimer's Disease, vol. 69, no. 3, pp. 717-727. https://doi.org/10.3233/JAD-181203
Eakin, Kelsey A. ; Saleem, Mahwesh ; Herrmann, Nathan ; Cogo-Moreira, Hugo ; Mielke, Michelle M ; Oh, Paul I. ; Haughey, Norman J. ; Venkata, Swarajya L.V. ; Lanctôt, Krista L. ; Swardfager, Walter. / Plasma Sphingolipids Mediate a Relationship between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise. In: Journal of Alzheimer's Disease. 2019 ; Vol. 69, No. 3. pp. 717-727.
@article{cdcb20735d91492aa8ac40d326b03833,
title = "Plasma Sphingolipids Mediate a Relationship between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise",
abstract = "Background: Exercise prevents recurrent cardiovascular events and it may combat cognitive decline in coronary artery disease (CAD); however, evidence in type 2 diabetes (T2DM) has been mixed. T2DM and memory decline have been associated with differences in the plasma sphingolipidome. Objective: Here, we will investigate whether T2DM-related sphingolipids predict less memory improvement over an exercise intervention for CAD. Methods: Among participants with CAD entering a 6-month exercise intervention, we matched 20 with T2DM to 40 without T2DM for age, sex, and body mass index. We assessed 45 sphingolipid species using high-performance liquid chromatography coupled electrospray ionization tandem mass spectrometry with multiple reaction monitoring. We assessed memory using the California Verbal Learning Test, 2nd Ed, and the revised Brief Visuospatial Learning Test. Results: Partial least squares discriminant analysis identified 8 species that distinguished T2DM from non-T2DM groups with 83{\%} (95{\%} confidence interval [70{\%}, 95{\%}]) accuracy in a receiver operator characteristic curve (validated by internal resampling, 1000 permutations, p=0.01). At baseline, T2DM-associated sphingolipids (ceramide C22:0, monohexylceramide C16:1, and lactosylceramide C24:0) were associated with poorer memory, attention, and psychomotor processing speed performance. Among 50 completers, an indirect effect of T2DM on less improvement in verbal memory was mediated by monohexylceramide C16:1 (0.86 fewer words recalled, 95{\%} bootstrap confidence interval [-2.32, -0.24]), and an indirect effect of T2DM on less visuospatial memory improvement was mediated by ceramide C22:0 concentrations (0.42 fewer points, 95{\%} bootstrap confidence interval [-1.17, -0.05]). Conclusions: Ceramide species associated with T2DM predicted poorer cognitive responses to exercise in patients with CAD.",
keywords = "Cognition, coronary artery disease, exercise, memory, sphingolipids, type 2 diabetes",
author = "Eakin, {Kelsey A.} and Mahwesh Saleem and Nathan Herrmann and Hugo Cogo-Moreira and Mielke, {Michelle M} and Oh, {Paul I.} and Haughey, {Norman J.} and Venkata, {Swarajya L.V.} and Lanct{\^o}t, {Krista L.} and Walter Swardfager",
year = "2019",
month = "1",
day = "1",
doi = "10.3233/JAD-181203",
language = "English (US)",
volume = "69",
pages = "717--727",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Plasma Sphingolipids Mediate a Relationship between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise

AU - Eakin, Kelsey A.

AU - Saleem, Mahwesh

AU - Herrmann, Nathan

AU - Cogo-Moreira, Hugo

AU - Mielke, Michelle M

AU - Oh, Paul I.

AU - Haughey, Norman J.

AU - Venkata, Swarajya L.V.

AU - Lanctôt, Krista L.

AU - Swardfager, Walter

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Exercise prevents recurrent cardiovascular events and it may combat cognitive decline in coronary artery disease (CAD); however, evidence in type 2 diabetes (T2DM) has been mixed. T2DM and memory decline have been associated with differences in the plasma sphingolipidome. Objective: Here, we will investigate whether T2DM-related sphingolipids predict less memory improvement over an exercise intervention for CAD. Methods: Among participants with CAD entering a 6-month exercise intervention, we matched 20 with T2DM to 40 without T2DM for age, sex, and body mass index. We assessed 45 sphingolipid species using high-performance liquid chromatography coupled electrospray ionization tandem mass spectrometry with multiple reaction monitoring. We assessed memory using the California Verbal Learning Test, 2nd Ed, and the revised Brief Visuospatial Learning Test. Results: Partial least squares discriminant analysis identified 8 species that distinguished T2DM from non-T2DM groups with 83% (95% confidence interval [70%, 95%]) accuracy in a receiver operator characteristic curve (validated by internal resampling, 1000 permutations, p=0.01). At baseline, T2DM-associated sphingolipids (ceramide C22:0, monohexylceramide C16:1, and lactosylceramide C24:0) were associated with poorer memory, attention, and psychomotor processing speed performance. Among 50 completers, an indirect effect of T2DM on less improvement in verbal memory was mediated by monohexylceramide C16:1 (0.86 fewer words recalled, 95% bootstrap confidence interval [-2.32, -0.24]), and an indirect effect of T2DM on less visuospatial memory improvement was mediated by ceramide C22:0 concentrations (0.42 fewer points, 95% bootstrap confidence interval [-1.17, -0.05]). Conclusions: Ceramide species associated with T2DM predicted poorer cognitive responses to exercise in patients with CAD.

AB - Background: Exercise prevents recurrent cardiovascular events and it may combat cognitive decline in coronary artery disease (CAD); however, evidence in type 2 diabetes (T2DM) has been mixed. T2DM and memory decline have been associated with differences in the plasma sphingolipidome. Objective: Here, we will investigate whether T2DM-related sphingolipids predict less memory improvement over an exercise intervention for CAD. Methods: Among participants with CAD entering a 6-month exercise intervention, we matched 20 with T2DM to 40 without T2DM for age, sex, and body mass index. We assessed 45 sphingolipid species using high-performance liquid chromatography coupled electrospray ionization tandem mass spectrometry with multiple reaction monitoring. We assessed memory using the California Verbal Learning Test, 2nd Ed, and the revised Brief Visuospatial Learning Test. Results: Partial least squares discriminant analysis identified 8 species that distinguished T2DM from non-T2DM groups with 83% (95% confidence interval [70%, 95%]) accuracy in a receiver operator characteristic curve (validated by internal resampling, 1000 permutations, p=0.01). At baseline, T2DM-associated sphingolipids (ceramide C22:0, monohexylceramide C16:1, and lactosylceramide C24:0) were associated with poorer memory, attention, and psychomotor processing speed performance. Among 50 completers, an indirect effect of T2DM on less improvement in verbal memory was mediated by monohexylceramide C16:1 (0.86 fewer words recalled, 95% bootstrap confidence interval [-2.32, -0.24]), and an indirect effect of T2DM on less visuospatial memory improvement was mediated by ceramide C22:0 concentrations (0.42 fewer points, 95% bootstrap confidence interval [-1.17, -0.05]). Conclusions: Ceramide species associated with T2DM predicted poorer cognitive responses to exercise in patients with CAD.

KW - Cognition

KW - coronary artery disease

KW - exercise

KW - memory

KW - sphingolipids

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85067091299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067091299&partnerID=8YFLogxK

U2 - 10.3233/JAD-181203

DO - 10.3233/JAD-181203

M3 - Article

C2 - 31006687

AN - SCOPUS:85067091299

VL - 69

SP - 717

EP - 727

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -